Design Therapeutics Cash Flow Statement (2020-2026) | DSGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Depreciation and Depletion (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Share-based Compensation (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Gains from Investment Securities (Quarter)			0.00B	0.01B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Non-cash Items (Quarter)			0.04B				10.53B				1.12B				19.65B				53.72B
Cash from Operations (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.02B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Change in Working Capital
Change in Accured Expenses (Quarter)	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B
Investing Activities
Capital Expenditures (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B		0.00B	0.00B		0.00B
Change in Acquisitions & Divestments (Quarter)	0.01B	0.00B	0.00B	0.00B	0.00B	0.03B	0.06B	0.05B	0.07B	0.07B	0.08B	0.07B	0.08B	0.06B	0.07B	0.09B	0.06B	0.08B	0.08B	0.04B
Cash from Investing Activities (Quarter)	-0.02B	-0.01B	-0.05B	0.00B	-0.16B	-0.06B	-0.00B	0.02B	0.01B	0.02B	0.01B	0.02B	0.03B	-0.01B	0.00B	0.01B	0.02B	0.01B	-0.01B	-0.01B
Financing Activities
Change in Capital Stock
Shares Issued (Quarter)	-0.00B		-0.25B	0.00B		0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.02B
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.03B	0.02B
Change in Cash (Quarter)	-0.03B	-0.01B	-0.06B	-0.01B	-0.17B	-0.08B	-0.02B	0.00B	-0.00B	0.00B	-0.01B	0.01B	0.02B	-0.02B	-0.01B	-0.01B	0.01B	-0.00B	0.00B	-0.00B
Free Cash Flow (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.02B
Net Cash Flow (Quarter)	-0.03B	-0.01B	-0.06B	-0.01B	-0.17B	-0.08B	-0.02B	0.00B	-0.00B	0.00B	-0.01B	0.01B	0.02B	-0.02B	-0.01B	-0.01B	0.01B	-0.00B	0.00B	-0.00B

Research Tools

Design Therapeutics Cash Flow Statement (2020-2026) | DSGN

Create an account

Sign In

Reset Password